Roberta Gualtierotti: Modern Approaches to Diagnosis and Treatment of Hemophilia A and B
Roberta Gualtierotti, Associate Professor of Internal Medicine at the University of Milan, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in JTH:
“From factor and non-factor replacement to gene therapy, hemophilia management is evolving rapidly, while hemophilic arthropathy remains a major unmet need.
Proud to share our educational review on the diagnosis and management of Hemophilia A and B, covering genetics, musculoskeletal complications, innovative therapies, cardiovascular comorbidities, and multidisciplinary care.
Educational Review in Press by the International Society on Thrombosis and Haemostasis (ISTH) SSC Subcommittee on FVIII and FIX.”
Title: Diagnosis and management of hemophilia A and B
Authors: Ming Y Lim, Jesús Ardila, Giancarlo Castaman, Yesim Dargaud, Karin Fijnvandraat, Roberta Gualtierotti, Cedric Hermans, Susan Shapiro
Other posts featuring Roberta Gualtierotti on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?